for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Company News

BRIEF-Prometic Life Sciences Q4 Total Revenue $6.6 Mln Vs $4.1 Mln

March 28 (Reuters) - Prometic Life Sciences Inc:

* PROMETIC REPORTS ITS Q4-2017 AND YE-2017 FINANCIAL RESULTS AND PROVIDES UPDATE ON ACTIVITIES

* TOTAL REVENUES FOR Q4 ENDED DECEMBER 31, 2017 WERE $6.6 MILLION COMPARED TO $4.1 MILLION FOR Q4 ENDED DECEMBER 31, 2016

* PROMETIC LIFE SCIENCES - RECEIVED FDA INVESTIGATIONAL NEW DRUG (IND) APPROVAL TO COMMENCE ITS PIVOTAL PHASE 3 CLINICAL TRIAL OF PBI-4050 DRUG Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up